Bright Path Laboratories
Santa Fe, US · Founded 2017 · Delaware corporation
Founders & leadership
AJ
Anthony J. QuinonesNamed on SEC filing
MG
Michael GonzalesNamed on SEC filing
PL
Phil LichtenbergerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.5M disclosed across 1 round · 2021
▶$8.5MraisedNov 2021 · 17 investors · PharmaceuticalsRule 506(b)
▶$8.5MraisedNov 2021 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony J. QuinonesExecutive Officer, Director
- Michael GonzalesExecutive Officer
- Phil LichtenbergerExecutive Officer
- Offering amount
- $14M
- Amount sold
- $8.5M
- Proceeds to insiders
- $570K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Bright Path Laboratories raised?
- Bright Path Laboratories has disclosed $8.5M raised across 1 round.
- Where is Bright Path Laboratories headquartered?
- Bright Path Laboratories is headquartered in Santa Fe, US.